Arch Chemicals Inc. Files Petition with the U.S. Department of Commerce

December 19,2013

Arch Chemicals Inc. Files Petition with the U.S. Department of Commerce    

Basel, Switzerland, – Arch Chemicals, Inc., a Lonza company (“Lonza”), has announced today that it has filed a petition with the U.S. Department of Commerce and International Trade Commission to initiate antidumping and countervailing duty investigations with respect to Chinese calcium hypochlorite.  Calcium hypochlorite is a common sanitizer used in pools and spas and has a number of other uses.  Lonza has filed the petition on behalf of the domestic industry.   

The petition begins the process for imposing duties at the border to offset the advantage Chinese manufacturers have obtained in the market through unfair pricing and government subsidies.   “In recent years through aggressive tactics, the Chinese manufacturers have grabbed market share and threaten the viability of this product for us,” says Rick Walden, Senior Vice President.  “We feel the petition is necessary in order to create fair competition that benefits all.”  

Antidumping duties are designed to offset the advantage a foreign producer gains when it sells below the fair market value of a product, displacing the local production.  Countervailing duties are designed to offset the unfair advantages foreign producers gain through the receipt of subsidies from their government, in contravention of treaty obligations.  

About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers’ needs from research to final product manufacture. It is the global leader in the production and support of chemical and biological active pharmaceutical ingredients. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is also the world leader in microbial control providing innovative, chemistry-based and related solutions to destroy or to selectively inhibit the growth of harmful microorganisms. Its activities encompass the areas of water treatment, personal care, health and hygiene, industrial preservation, materials protection, and wood treatment. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition and agro markets.  Further information can be found at  

Further Information  
Lonza Group Ltd
Dominik Werner, Corporate Communications, Tel +41 61 316 8798,
Dirk Oehlers, Investor Relations, Tel +41 61 316 8540,
Melanie Disa, Media Relations, Tel +1 201 316 9413,

Browse All News